189 related articles for article (PubMed ID: 21420440)
1. Mildronate treatment improves functional recovery following middle cerebral artery occlusion in rats.
Svalbe B; Zvejniece L; Vavers E; Pugovics O; Muceniece R; Liepinsh E; Dambrova M
Behav Brain Res; 2011 Sep; 222(1):26-32. PubMed ID: 21420440
[TBL] [Abstract][Full Text] [Related]
2. The cardioprotective effect of mildronate is diminished after co-treatment with L-carnitine.
Kuka J; Vilskersts R; Cirule H; Makrecka M; Pugovics O; Kalvinsh I; Dambrova M; Liepinsh E
J Cardiovasc Pharmacol Ther; 2012 Jun; 17(2):215-22. PubMed ID: 21903968
[TBL] [Abstract][Full Text] [Related]
3. Mildronate, an inhibitor of carnitine biosynthesis, induces an increase in gamma-butyrobetaine contents and cardioprotection in isolated rat heart infarction.
Liepinsh E; Vilskersts R; Loca D; Kirjanova O; Pugovichs O; Kalvinsh I; Dambrova M
J Cardiovasc Pharmacol; 2006 Dec; 48(6):314-9. PubMed ID: 17204911
[TBL] [Abstract][Full Text] [Related]
4. Effect of inhibiting carnitine biosynthesis on male rat sexual performance.
Dambrova M; Cirule H; Svalbe B; Zvejniece L; Pugovichs O; Zorenko T; Kalvinsh I; Liepinsh E; Belozertseva I
Physiol Behav; 2008 Oct; 95(3):341-7. PubMed ID: 18640137
[TBL] [Abstract][Full Text] [Related]
5. Human umbilical cord blood cells do not improve sensorimotor or cognitive outcome following transient middle cerebral artery occlusion in rats.
Mäkinen S; Kekarainen T; Nystedt J; Liimatainen T; Huhtala T; Närvänen A; Laine J; Jolkkonen J
Brain Res; 2006 Dec; 1123(1):207-15. PubMed ID: 17070789
[TBL] [Abstract][Full Text] [Related]
6. Improved sensorimotor function by rolipram following focal cerebral ischemia in rats.
Hätinen S; Sairanen M; Sirviö J; Jolkkonen J
Restor Neurol Neurosci; 2008; 26(6):493-9. PubMed ID: 19096137
[TBL] [Abstract][Full Text] [Related]
7. The sensorimotor and cognitive deficits in rats following 90- and 120-min transient occlusion of the middle cerebral artery.
Zvejniece L; Svalbe B; Liepinsh E; Pulks E; Dambrova M
J Neurosci Methods; 2012 Jul; 208(2):197-204. PubMed ID: 22640751
[TBL] [Abstract][Full Text] [Related]
8. Protective effects of mildronate in an experimental model of type 2 diabetes in Goto-Kakizaki rats.
Liepinsh E; Vilskersts R; Zvejniece L; Svalbe B; Skapare E; Kuka J; Cirule H; Grinberga S; Kalvinsh I; Dambrova M
Br J Pharmacol; 2009 Aug; 157(8):1549-56. PubMed ID: 19594753
[TBL] [Abstract][Full Text] [Related]
9. Elevated vascular γ-butyrobetaine levels attenuate the development of high glucose-induced endothelial dysfunction.
Vilskersts R; Zharkova-Malkova O; Mezhapuke R; Grinberga S; Cirule H; Dambrova M
Clin Exp Pharmacol Physiol; 2013 Aug; 40(8):518-24. PubMed ID: 23710938
[TBL] [Abstract][Full Text] [Related]
10. Effects of long-term mildronate treatment on cardiac and liver functions in rats.
Liepinsh E; Kuka J; Svalbe B; Vilskersts R; Skapare E; Cirule H; Pugovics O; Kalvinsh I; Dambrova M
Basic Clin Pharmacol Toxicol; 2009 Dec; 105(6):387-94. PubMed ID: 19663820
[TBL] [Abstract][Full Text] [Related]
11. Endothelium- and nitric oxide-dependent vasorelaxing activities of gamma-butyrobetaine esters: possible link to the antiischemic activities of mildronate.
Sjakste N; Kleschyov AL; Boucher JL; Baumane L; Dzintare M; Meirena D; Sjakste J; Sydow K; Münzel T; Kalvinsh I
Eur J Pharmacol; 2004 Jul; 495(1):67-73. PubMed ID: 15219822
[TBL] [Abstract][Full Text] [Related]
12. Dalfampridine improves sensorimotor function in rats with chronic deficits after middle cerebral artery occlusion.
Iaci JF; Parry TJ; Huang Z; Finklestein SP; Ren J; Barrile DK; Davenport MD; Wu R; Blight AR; Caggiano AO
Stroke; 2013 Jul; 44(7):1942-50. PubMed ID: 23652269
[TBL] [Abstract][Full Text] [Related]
13. The neuroprotective effects of R-phenibut after focal cerebral ischemia.
Vavers E; Zvejniece L; Svalbe B; Volska K; Makarova E; Liepinsh E; Rizhanova K; Liepins V; Dambrova M
Pharmacol Res; 2016 Nov; 113(Pt B):796-801. PubMed ID: 26621244
[TBL] [Abstract][Full Text] [Related]
14. Treatment of rats with pioglitazone in the reperfusion phase of focal cerebral ischemia: a preclinical stroke trial.
Culman J; Nguyen-Ngoc M; Glatz T; Gohlke P; Herdegen T; Zhao Y
Exp Neurol; 2012 Dec; 238(2):243-53. PubMed ID: 22995601
[TBL] [Abstract][Full Text] [Related]
15. Mildronate, a regulator of energy metabolism, reduces atherosclerosis in apoE/LDLR-/- mice.
Vilskersts R; Liepinsh E; Mateuszuk L; Grinberga S; Kalvinsh I; Chlopicki S; Dambrova M
Pharmacology; 2009; 83(5):287-93. PubMed ID: 19325254
[TBL] [Abstract][Full Text] [Related]
16. Mildronate treatment alters γ-butyrobetaine and l-carnitine concentrations in healthy volunteers.
Liepinsh E; Konrade I; Skapare E; Pugovics O; Grinberga S; Kuka J; Kalvinsh I; Dambrova M
J Pharm Pharmacol; 2011 Sep; 63(9):1195-201. PubMed ID: 21827492
[TBL] [Abstract][Full Text] [Related]
17. Testosterone enhances functional recovery after stroke through promotion of antioxidant defenses, BDNF levels and neurogenesis in male rats.
Fanaei H; Karimian SM; Sadeghipour HR; Hassanzade G; Kasaeian A; Attari F; Khayat S; Ramezani V; Javadimehr M
Brain Res; 2014 Apr; 1558():74-83. PubMed ID: 24565925
[TBL] [Abstract][Full Text] [Related]
18. Mildronate, the inhibitor of L-carnitine transport, induces brain mitochondrial uncoupling and protects against anoxia-reoxygenation.
Makrecka M; Svalbe B; Volska K; Sevostjanovs E; Liepins J; Grinberga S; Pugovics O; Liepinsh E; Dambrova M
Eur J Pharmacol; 2014 Jan; 723():55-61. PubMed ID: 24333219
[TBL] [Abstract][Full Text] [Related]
19. An optimized dosing regimen of cimaglermin (neuregulin 1β3, glial growth factor 2) enhances molecular markers of neuroplasticity and functional recovery after permanent ischemic stroke in rats.
Iaci JF; Parry TJ; Huang Z; Pavlopoulos E; Finklestein SP; Ren J; Caggiano A
J Neurosci Res; 2016 Mar; 94(3):253-65. PubMed ID: 26660233
[TBL] [Abstract][Full Text] [Related]
20. Differential effect of the alpha2-adrenoceptor antagonist, atipamezole, in limb-placing task and skilled forepaw use following experimental stroke.
Butovas S; Lukkarinen J; Virtanen T; Jolkkonen J; Sivenius J
Restor Neurol Neurosci; 2001; 18(4):143-51. PubMed ID: 11847437
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
